Literature DB >> 2241932

Slow tight-binding inhibition of prolyl endopeptidase by benzyloxycarbonyl-prolyl-prolinal.

A V Bakker1, S Jung, R W Spencer, F J Vinick, W S Faraci.   

Abstract

Prolyl endopeptidase is a serine proteinase that specifically cleaves peptides on the carboxy side of proline residues. Wilk & Orlowski [(1983) J. Neurochem. 41, 69-75] have shown that benzyloxycarbonyl-prolyl-prolinal (Z-prolyl-prolinal) is a potent inhibitor of prolyl endopeptidase. We show that Z-prolyl-prolinal is a slow-binding inhibitor of mouse brain prolyl endopeptidase with Ki 0.35 +/- 0.05 nM. Kinetic analysis indicates that the mechanism is a simple, but slow, reversible equilibrium between free and bound enzyme (E + I in equilibrium EI) with rate constants for association (kon) and dissociation (koff) of 1.6 X 10(5) M-1.s-1 and approx. 4 X 10(-5) s-1 respectively. Slow-binding inhibition is dependent on the presence of the aldehyde group since the alcohol (Z-prolyl-prolinol) is a rapid and 50,000-fold poorer inhibitor (Ki 19 microM). Prolyl endopeptidase from human brain is also inhibited by Z-prolyl-prolinal with kinetics similar to those of the mouse brain enzyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2241932      PMCID: PMC1149592          DOI: 10.1042/bj2710559

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  Mechanism of association of a specific aldehyde "transition-state analogue" to the active site of alpha-chymotrypsin.

Authors:  W P Kennedy; R M Schultz
Journal:  Biochemistry       Date:  1979-01-23       Impact factor: 3.162

2.  Thiazolidine derivatives as potent inhibitors specific for prolyl endopeptidase.

Authors:  D Tsuru; T Yoshimoto; N Koriyama; S Furukawa
Journal:  J Biochem       Date:  1988-10       Impact factor: 3.387

3.  1-Aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behavior.

Authors:  M D Erion; C T Walsh
Journal:  Biochemistry       Date:  1987-06-16       Impact factor: 3.162

4.  Purification and properties of a prolyl endopeptidase from rabbit brain.

Authors:  M Orlowski; E Wilk; S Pearce; S Wilk
Journal:  J Neurochem       Date:  1979-08       Impact factor: 5.372

5.  Statistical analysis of enzyme kinetic data.

Authors:  W W Cleland
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

6.  Kinetics and mechanism of human leukocyte elastase inactivation by ynenol lactones.

Authors:  L J Copp; A Krantz; R W Spencer
Journal:  Biochemistry       Date:  1987-01-13       Impact factor: 3.162

7.  Inhibition of rabbit brain prolyl endopeptidase by n-benzyloxycarbonyl-prolyl-prolinal, a transition state aldehyde inhibitor.

Authors:  S Wilk; M Orlowski
Journal:  J Neurochem       Date:  1983-07       Impact factor: 5.372

8.  Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man.

Authors:  T Yoshimoto; K Ogita; R Walter; M Koida; D Tsuru
Journal:  Biochim Biophys Acta       Date:  1979-08-15

Review 9.  Prolyl endopeptidase.

Authors:  S Wilk
Journal:  Life Sci       Date:  1983-11-28       Impact factor: 5.037

10.  Mechanism of slow-binding inhibition of human leukocyte elastase by trifluoromethyl ketones.

Authors:  R L Stein; A M Strimpler; P D Edwards; J J Lewis; R C Mauger; J A Schwartz; M M Stein; D A Trainor; R A Wildonger; M A Zottola
Journal:  Biochemistry       Date:  1987-05-19       Impact factor: 3.162

View more
  15 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Benzyloxycarbonyl-proline-prolinal (ZPP): Dual complementary roles for neutrophil inhibition.

Authors:  D W Russell; M Hardison; K R Genschmer; T Szul; P E Bratcher; M Abdul Roda; X Xu; L Viera; J E Blalock; A Gaggar; B D Noerager
Journal:  Biochem Biophys Res Commun       Date:  2019-08-07       Impact factor: 3.575

3.  Substrate- and pH-dependent contribution of oxyanion binding site to the catalysis of prolyl oligopeptidase, a paradigm of the serine oligopeptidase family.

Authors:  Z Szeltner; V Renner; L Polgár
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

4.  TLXI, a novel type of xylanase inhibitor from wheat (Triticum aestivum) belonging to the thaumatin family.

Authors:  Ellen Fierens; Sigrid Rombouts; Kurt Gebruers; Hans Goesaert; Kristof Brijs; Johnny Beaugrand; Guido Volckaert; Steven Van Campenhout; Paul Proost; Christophe M Courtin; Jan A Delcour
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

5.  Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.

Authors:  Nadja Grobe; Nathan M Weir; Orly Leiva; Frank S Ong; Kenneth E Bernstein; Alvin H Schmaier; Mariana Morris; Khalid M Elased
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-07       Impact factor: 4.249

6.  Activity-based probes for monitoring postproline protease activity.

Authors:  Eduard Sabidó; Teresa Tarragó; Sherry Niessen; Benjamin F Cravatt; Ernest Giralt
Journal:  Chembiochem       Date:  2009-09-21       Impact factor: 3.164

7.  Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.

Authors:  Jarkko I Venäläinen; Risto O Juvonen; J Arturo Garcia-Horsman; Erik A A Wallén; Johannes A M Christiaans; Elina M Jarho; Jukka Gynther; Pekka T Männistö
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 8.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

9.  A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.

Authors:  Amit Gaggar; Patricia L Jackson; Brett D Noerager; Philip J O'Reilly; D Brent McQuaid; Steven M Rowe; J P Clancy; J Edwin Blalock
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD.

Authors:  Philip O'Reilly; Patricia L Jackson; Brett Noerager; Suzanne Parker; Mark Dransfield; Amit Gaggar; J Edwin Blalock
Journal:  Respir Res       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.